Initiating and Titrating Regular (Short‑Acting) Insulin for Persistent Post‑Prandial Hyperglycemia

Add regular insulin at 4 units before the largest meal (or 10 % of your current basal dose) immediately, then titrate by 1–2 units every 3 days based on 2‑hour post‑meal glucose readings until post‑prandial values fall below 180 mg/dL. 1, 2

When to Add Prandial Insulin

Your fasting glucose is at target on basal insulin, but your HbA1c remains above 7 % after 3 months of optimized metformin (2000 mg daily) and basal insulin—this pattern indicates that post‑prandial hyperglycemia is the primary driver of your elevated HbA1c and requires mealtime insulin coverage. 1, 3, 4
When basal insulin has been titrated to achieve acceptable fasting glucose (80–130 mg/dL) but HbA1c stays above goal, adding prandial insulin is the next step rather than further basal escalation. 1, 2
Post‑prandial glucose contributes approximately 80 % of HbA1c when HbA1c is near 7 %, making prandial control essential for reaching your target. 4

Initial Dosing of Regular Insulin

Start with 4 units of regular insulin administered 30–45 minutes before the largest meal of the day (typically dinner or lunch, whichever causes the greatest glucose excursion). 1, 2, 5
An alternative starting dose is 10 % of your current basal insulin dose—for example, if you take 40 units of basal insulin, begin with 4 units of regular insulin before the largest meal. 1, 2
Regular insulin has a slower onset (30–60 minutes) and longer duration (6–8 hours) compared with rapid‑acting analogs, so it must be given 30–45 minutes before eating to align peak insulin action with the post‑meal glucose rise. 5, 6

Titration Protocol

Increase the regular insulin dose by 1–2 units (approximately 10–15 %) every 3 days based on the 2‑hour post‑prandial glucose reading after that specific meal. 1, 2, 7
Target post‑prandial glucose < 180 mg/dL (10 mmol/L) at 2 hours after the start of the meal. 1, 2, 5
If the 2‑hour post‑meal glucose consistently exceeds 180 mg/dL over 3 consecutive days, increase the dose by 1–2 units before the next 3‑day cycle. 1, 2
If any glucose reading falls < 70 mg/dL, reduce the implicated insulin dose by 10–20 % immediately and treat with 15 g of fast‑acting carbohydrate. 1, 2

Expanding to Multiple Meals

Once the first meal's post‑prandial glucose is controlled (< 180 mg/dL), add regular insulin before the second‑largest meal using the same starting dose (4 units or 10 % of basal) and titration schedule. 1, 7
Continue this stepwise approach—adding one meal at a time—until all meals with significant post‑prandial excursions are covered. 1, 7
Most patients will require prandial insulin before two or three meals per day to achieve HbA1c < 7 %. 1, 7

Monitoring Requirements

Check 2‑hour post‑prandial glucose after each meal where you administer regular insulin to guide dose adjustments. 1, 2, 4
Check fasting glucose daily to ensure your basal insulin remains appropriately dosed; fasting glucose should stay 80–130 mg/dL. 1, 2
Measure HbA1c every 3 months during intensive titration to assess overall glycemic control. 1, 2
Perform a minimum of 4 glucose checks per day (fasting, before meals, and 2‑hour post‑prandial) during the titration phase. 1, 2

Basal Insulin Considerations

Do not increase basal insulin beyond 0.5 units/kg/day (approximately 35–40 units for most adults) without first addressing post‑prandial hyperglycemia with prandial insulin. 1, 2
Signs of "over‑basalization" include: basal dose > 0.5 units/kg/day, bedtime‑to‑morning glucose drop ≥ 50 mg/dL, hypoglycemia despite overall hyperglycemia, or high day‑to‑day glucose variability. 1, 2
If your basal insulin dose is already at or above this threshold, focus on titrating prandial insulin rather than further basal escalation. 1, 2

Metformin Continuation

Continue metformin at 2000 mg daily (1000 mg twice daily with meals) throughout insulin intensification unless contraindicated. 1, 2
Metformin reduces total insulin requirements by 20–30 % and provides superior glycemic control compared with insulin alone. 1, 2
Never discontinue metformin when adding prandial insulin unless specific contraindications exist (e.g., acute illness, renal impairment with eGFR < 30 mL/min/1.73 m², tissue hypoxia). 1, 2

Regular Insulin vs. Rapid‑Acting Analogs

Rapid‑acting insulin analogs (lispro, aspart, glulisine) offer advantages over regular insulin: they can be administered 0–15 minutes before meals (versus 30–45 minutes for regular insulin), have a faster onset and shorter duration, and provide better post‑prandial glucose control with less delayed hypoglycemia. 5, 6
If you have access to rapid‑acting analogs, they are the preferred prandial insulin due to their more physiologic profile and greater convenience. 5, 6
However, regular insulin remains an effective and less expensive alternative when rapid‑acting analogs are unavailable or unaffordable. 5

Correction (Supplemental) Dosing

In addition to scheduled prandial insulin, you may add correction doses when pre‑meal glucose exceeds target:
- Add 2 units for pre‑meal glucose > 250 mg/dL (13.9 mmol/L). 1, 2
- Add 4 units for pre‑meal glucose > 350 mg/dL (19.4 mmol/L). 1, 2
Correction insulin must supplement—not replace—your scheduled prandial dose; never rely on correction insulin alone. 1, 2

Expected Clinical Outcomes

With properly implemented basal‑plus‑prandial therapy, approximately 68 % of patients achieve mean glucose < 140 mg/dL, compared with only 38 % using inadequate insulin regimens. 1, 2
Adding prandial insulin to optimized basal insulin typically produces an HbA1c reduction of 1.0–1.5 % over 3–6 months. 1, 3, 7
94 % of patients achieving post‑prandial glucose < 140 mg/dL reach an HbA1c < 7 %, whereas only 64 % of those achieving fasting glucose targets alone do so. 4
Properly executed basal‑plus‑prandial regimens do not increase overall hypoglycemia incidence compared with inadequate basal‑only approaches. 1, 2

Safety and Hypoglycemia Management

Treat any glucose < 70 mg/dL immediately with 15 g of fast‑acting carbohydrate (e.g., 4 glucose tablets or 4 oz juice), recheck in 15 minutes, and repeat if needed. 1, 2
Never administer regular insulin at bedtime as a sole correction dose, as this markedly raises the risk of nocturnal hypoglycemia due to its prolonged duration of action. 1, 2
If hypoglycemia occurs without an obvious cause (e.g., missed meal, unusual exercise), reduce the implicated insulin dose by 10–20 % before the next administration. 1, 2

Common Pitfalls to Avoid

Do not delay adding prandial insulin when fasting glucose is at target but HbA1c remains above 7 % after 3–6 months—this pattern clearly indicates the need for mealtime coverage. 1, 3, 4
Do not continue escalating basal insulin beyond 0.5–1.0 units/kg/day without addressing post‑prandial hyperglycemia; this leads to "over‑basalization" with increased hypoglycemia risk and suboptimal control. 1, 2
Do not rely solely on correction (sliding‑scale) insulin without scheduled prandial doses; correction insulin must supplement, not replace, scheduled insulin. 1, 2
Do not discontinue metformin when adding prandial insulin unless contraindicated, as this leads to higher insulin requirements and greater weight gain. 1, 2

Alternative: GLP‑1 Receptor Agonist

If you prefer to avoid multiple daily injections, consider adding a GLP‑1 receptor agonist (e.g., semaglutide, dulaglutide) instead of prandial insulin when basal insulin exceeds 0.5 units/kg/day without achieving targets. 1, 2
GLP‑1 receptor agonists provide comparable post‑prandial glucose control with lower hypoglycemia risk and weight loss rather than weight gain. 1, 2
This combination (basal insulin + GLP‑1 RA) is particularly beneficial if you have cardiovascular disease, heart failure, or chronic kidney disease. 1, 2

Help us tailor your experience